Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2000
12/20/2000EP1060171A2 Tryptase inhibitors
12/20/2000EP1060167A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed et a?/et b?-receptor antagonists
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000EP1059921A2 Use of macrolide compounds for the treatment of ards
12/20/2000EP1059917A1 Anti-asthma therapy
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000CN1277604A Heteraryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/20/2000CN1277051A Recipe of externally applied Chinese medicine for rheumatism and asthma
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
12/19/2000US6162819 Pyrazole derivatives, their preparation and their use in pharmaceuticals
12/19/2000US6162817 Stroke therapy; brain disorders; crohn's disease
12/19/2000US6162808 Compounds
12/19/2000US6162790 Oligopeptides
12/19/2000US6162431 Serine/threonine protein kinase
12/19/2000CA2189527C Novel elastase inhibitors
12/19/2000CA2159787C Dibenzofuran aromatic derivatives; pharmaceutical and cosmetic compositions containing the same
12/19/2000CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000075131A1 Substituted pyrazole compounds
12/14/2000WO2000075130A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
12/14/2000WO2000075127A1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
12/14/2000WO2000075126A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000WO2000075114A1 Beta2-adrenoceptor agonists
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000048624A3 Utilization of orosomucoid in order to produce a pharmaceutical preparation
12/14/2000WO2000044763A3 Compositions for treating inflammatory response
12/14/2000WO2000033872A9 Method of and compositions for immunization with the pseudomonas v antigen
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2376010A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000CA2375985A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/14/2000CA2370013A1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
12/14/2000CA2293162A1 Acidic buffered nasal spray
12/13/2000EP1059084A2 Rapidly absorbed liquid compositions containing an amine and a NSAID
12/13/2000EP1058680A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
12/13/2000EP0601062B2 Sirs vaccine and diagnosis method
12/13/2000CN1276785A N-aroylphenylalanine derivs.
12/13/2000CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency
12/13/2000CN1276242A Chinese medicine for curing cough and asthma
12/13/2000CN1276213A Medicine for treating diseases in chicken respiratory tract
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/13/2000CN1059341C Patch for external use for treatment of cold
12/13/2000CN1059327C Plaster for treatment of child asthma
12/13/2000CN1059323C Chinese medicine for treating phinitis diseases
12/13/2000CN1059320C Sugar-free sarcandra glabra lozenge
12/12/2000US6160175 Naphthyl acetamides as sPLA2 inhibitors
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6159998 Administered as vasodilators, analgesics, anesthetics, sedatives, and anitspasmodic agents
12/12/2000US6159952 Bronchodilator agents
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000CA2058560C Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
12/10/2000CA2311039A1 Rapidly absorbed liquid compositions
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073307A2 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000WO2000073302A1 Oxazaheterocycles as protease inhibitors
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073282A1 Il-8 receptor antagonists
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073279A1 4-phenyl-pyrimidine derivatives
12/07/2000WO2000073278A2 5-phenyl-pyrimidine derivatives
12/07/2000WO2000073276A2 Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000WO2000073275A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000073253A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS
12/07/2000WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072815A1 Indole derivatives
12/07/2000WO2000048626A3 Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammation associated with pulmonary disease
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
12/07/2000DE19924892A1 Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their preparation and use as endothelin receptor antagonists
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375666A1 Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000CA2375348A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2375186A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374295A1 Il-8 receptor antagonists
1 ... 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 ... 878